Importantly, abnormal regulation of KAT6A and KAT6B has been shown to serve as tumor drivers or suppressors, which places a critical impact on the formation, progression, and drug resistance of cancerous disorders [30, 31, 32, 100]. Here, KAT6A is linked to neoplasm.